Observed racial disparity in the negative predictive value of multi-parametric MRI for the diagnosis for prostate cancer.

Despite advances in the screening for PCa, there are disparities noted in the efficacy of screening tools between AAs and CAUs. For this reason, patients should be risk stratified and their screening results should be evaluated with consideration given to their baseline risk.